Latest News and Press Releases

Study CL-QRX003-002 will test whole-body application of QRX003 in conjunction with off-label systemic therapy in approximately 12-15 subjects.Study CL-QRX003-002 complements first whole-body pivotal...

- Company to host conference call Today, Thursday, May 22nd at 11am ET/8am PT -  NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 22, 2025 (GLOBE...

•  BLA priority review of RP1 plus nivolumab in advanced melanoma proceeding on schedule; manufacturing inspections and late cycle review meeting complete •  Full commercial infrastructure for launch...

CHATHAM, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company with marketed products and a pipeline of development...

Early results demonstrate near-complete elimination of tricuspid regurgitation in implanted patients with favorable safety profile and no permanent pacemaker implantations Paris, France and Munich,...

Ernst & Young (EY) US Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award finalist

LOS ALTOS, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today...

Purified Cortrophin Gel is the only ACTH therapy approved by the FDA for the treatment of acute gout flares Trial to be conducted by Dr. Hyon Choi at Massachusetts General Hospital and will compare...

Luton, Bedfordshire, United Kingdom, May 22, 2025 (GLOBE NEWSWIRE) -- The global ultrafine pulverizer market is valued at approximately USD 1.2 billion in 2024, with a robust growth trajectory...

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Semaglutide Market Size, Share & Trends Analysis Report by Product (Ozempic, Wegovy, Rybelsus), Application (Type 2 Diabetes Mellitus, Obesity),...

Early results demonstrate near-complete elimination of tricuspid regurgitation in implanted patients with favorable safety profile and no permanent pacemaker implantations Paris, France and Munich,...

Luton, Bedfordshire, United Kingdom, May 22, 2025 (GLOBE NEWSWIRE) -- The global rehabilitation robotic system market is valued at approximately $3.5 billion in 2024, with projections indicating...

Luton, Bedfordshire, United Kingdom, May 22, 2025 (GLOBE NEWSWIRE) -- The global thermal forming materials market is poised for substantial growth, with a projected value of approximately $6.5...

BERLIN, May 22, 2025 (GLOBE NEWSWIRE) -- Clue, the data-driven women's health intelligence platform, today announced it has reached 1 million paid subscribers, more than doubling its subscriber base...

NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...

Sanofi va acquérir Vigil Neuroscience, Inc. et ajouter un nouveau médicament expérimental pour le traitement de la maladie d’Alzheimer à son portefeuille en neurologie Paris, le 22 mai 2025....

Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline Paris, May 22, 2025. Sanofi announced today that it has...

ATLANTA, May 21, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN) complied with federal securities laws. On...

VANCOUVER, BC and KIBBUTZ YIFAT, Israel, May 21, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) ("Beyond Oil" or the "Company"), a food-tech innovation company...

– Virtual KOL Event Tuesday, June 3, 2025 3:00pm ET – – Attend the event here: https://lifescievents.com/event/immix-asco – LOS ANGELES, CA, May 21, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc....

SOUTH SAN FRANCISCO, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company led oral and poster presentations of clinical and preclinical...

NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...

샌프란시스코, May 22, 2025 (GLOBE NEWSWIRE) -- TrialWire가 Fierce Biotech의 Fierce CRO Award 우수 환자 모집 및 유지 부문에서 최종 후보로 선정되었다. TrialWire는 AI와 알고리즘으로 구동되는 환자 모집 및 등록 플랫폼으로, Salesforce Health Cloud를 기반으로...

三藩市, May 22, 2025 (GLOBE NEWSWIRE) -- TrialWire 今天宣佈於 Fierce CRO Award 的 「傑出患者招募及保留」類別中，獲 Fierce Biotech 挑選成為參加決賽的一分子。 TrialWire 是一個建構於 Salesforce Health Cloud 之上，採用人工智能及演算法驅動的患者招募和註冊平台，以確保一流的數據和...

旧金山, May 22, 2025 (GLOBE NEWSWIRE) -- TrialWire 今日宣布荣获 Fierce Biotech 主办的 Fierce CRO 奖项杰出患者招募与留存类目提名，闯入决赛。 TrialWire 是基于 Salesforce Health Cloud 构建的人工智能和算法驱动的患者招募和入组特色平台，具备一流的数据和知识产权安全保障。 ...

Chicago, May 21, 2025 (GLOBE NEWSWIRE) -- The global hair transplant market was valued at 7.62 billion in 2024 and is anticipated to reach US$ 41.01 billion by 2033, growing at a CAGR of 20.47%...

NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, alerts investors that a securities...

BENSALEM, Pa., May 21, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...

Dublin, May 21, 2025 (GLOBE NEWSWIRE) -- The "U.S. Medical Device Outsourcing Market Size, Share & Trends Analysis Report by Service (Quality Assurance, Contract Manufacturing), Application...

Austin, May 21, 2025 (GLOBE NEWSWIRE) -- Infection Control Market Size & Growth Analysis: According to SNS Insider, the Global Infection Control Market was valued at USD 234.91 billion in 2023...

FDA acknowledges that the benefit of repeat doses of COVID-19 vaccine boosters for Americans is uncertain; the updated regulatory framework for COVID-19 vaccines articulated by the Agency generally...

Trethera enlists leading expert in demyelinating diseases to advance TRE-515, a first-in-class drug with FDA Orphan Drug status for ADEM and optic neuritis

SARASOTA, FL, May 21, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug...

Viatris Inc. investors that lost money are encouraged to contact BFA Law before June 3, 2025 class action deadline.

IRVINE, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported financial...

Agency supports primary and novel secondary and exploratory endpoints proposed for Phase 3 Trial(s) Opportunity to utilize time-to-delay of levodopa/carbidopa initiation as an endpoint to measure...

American Oncology Network Expands Access to Advanced Radioligand Therapies Across U.S. Network

Route 92 Medical announces results of the SUMMIT MAX randomized clinical trial and receipt of a 510(k) clearance for the HiPoint 88 Reperfusion System.

Luton, Bedfordshire, United Kingdom, May 21, 2025 (GLOBE NEWSWIRE) -- Executive Summary The global portable otoscope market is valued at approximately $300 million in 2024 and is projected to reach...

Luton, Bedfordshire, United Kingdom, May 21, 2025 (GLOBE NEWSWIRE) -- Global Prostate Cancer Diagnostics Solution Market The global prostate cancer diagnostics solution market is undergoing a...

PITTSBURGH, May 21, 2025 (GLOBE NEWSWIRE) -- For countless individuals and their partners, the night often brings the disturbing sounds of snoring—a nightly symphony that disrupts sleep, leads to...

VALUE Phase III trial of EscharEx® in venous leg ulcers advancing as planned NexoBrid® manufacturing expansion on track; full operational capacity expected by year-end 2025 First quarter revenue of...

CARMEL, Ind., May 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing...

Investigator-initiated Phase 2 trial to evaluate TNX-102 SL’s potential to reduce severity of acute stress reaction (ASR) and frequency of acute stress disorder (ASD) Trial is sponsored by the...

LOS ALTOS, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ: UNCY) (“Unicycive” or the “Company”), a clinical stage biotechnology company developing therapies for...

VANCOUVER, British Columbia, May 21, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

Luton, Bedfordshire, United Kingdom, May 21, 2025 (GLOBE NEWSWIRE) -- The global angioplasty market for peripheral arterial disease (PAD) is expanding steadily, driven by rising PAD prevalence and...

Luton, Bedfordshire, United Kingdom, May 21, 2025 (GLOBE NEWSWIRE) -- The acidic bicarbonate concentrates market is driven by the use of specialized buffer solutions (often in combination with...

Designation is based on the pivotal Phase 3 DRAGON trial interim analysis results demonstrating Tinlarebant’s efficacy and favorable safety profileTrial completion expected by Q4 2025 (including a...

Groundbreaking procedures extend ONWARD’s leadership in the rapidly emerging brain-computer interface (BCI) fieldARC-BCI Therapy is designed to restore thought-driven movement after spinal cord injury...